TrialBMJ open2026

Breaking barriers: feasibility of a cluster randomised trial evaluating an instrument for identifying and ameliorating adverse drug reactions.

Vera Logan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.